🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 8 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/01/2018 | 4,58 | 5,13 | 4,50 | 4,85 | +4,53% | 13,76% | 3.402.000 |
| 03/01/2018 | 3,79 | 4,88 | 3,77 | 4,64 | +24,73% | 29,29% | 5.875.500 |
| 02/01/2018 | 3,69 | 3,83 | 3,57 | 3,72 | +1,09% | 7,05% | 778.300 |
| 29/12/2017 | 4,00 | 4,04 | 3,65 | 3,68 | -7,30% | 9,75% | 1.362.800 |
| 28/12/2017 | 3,86 | 4,03 | 3,86 | 3,97 | +3,39% | 4,40% | 1.110.700 |
| 27/12/2017 | 3,82 | 3,91 | 3,76 | 3,84 | +1,32% | 3,90% | 1.252.900 |
| 26/12/2017 | 3,70 | 3,86 | 3,62 | 3,79 | +2,16% | 6,49% | 1.054.500 |
| 22/12/2017 | 3,45 | 3,83 | 3,42 | 3,71 | +9,76% | 11,68% | 1.996.700 |
| 21/12/2017 | 3,40 | 3,54 | 3,37 | 3,38 | -1,46% | 5,00% | 1.106.000 |
| 20/12/2017 | 3,29 | 3,59 | 3,27 | 3,43 | +5,21% | 9,57% | 1.378.600 |
| 19/12/2017 | 3,25 | 3,38 | 3,23 | 3,26 | +0,93% | 4,71% | 1.128.600 |
| 18/12/2017 | 3,15 | 3,40 | 3,14 | 3,23 | +2,87% | 8,10% | 1.254.300 |
| 15/12/2017 | 3,19 | 3,20 | 3,08 | 3,14 | -0,32% | 3,76% | 1.305.600 |
| 14/12/2017 | 3,41 | 3,42 | 3,05 | 3,15 | -7,35% | 10,85% | 1.702.100 |
| 13/12/2017 | 3,30 | 3,41 | 3,01 | 3,40 | -4,23% | 12,12% | 2.036.700 |
| 12/12/2017 | 3,54 | 3,65 | 3,44 | 3,55 | +1,14% | 5,93% | 1.000.000 |
| 11/12/2017 | 3,45 | 3,60 | 3,37 | 3,51 | +1,74% | 6,52% | 939.500 |
| 08/12/2017 | 3,57 | 3,59 | 3,40 | 3,45 | -4,17% | 5,43% | 901.000 |
| 07/12/2017 | 3,43 | 3,68 | 3,42 | 3,60 | +4,05% | 7,58% | 1.765.400 |
| 06/12/2017 | 3,51 | 3,62 | 3,38 | 3,46 | +3,90% | 6,84% | 1.940.900 |
| 05/12/2017 | 3,33 | 3,46 | 3,30 | 3,33 | +0,00% | 4,80% | 538.200 |
| 04/12/2017 | 3,54 | 3,60 | 3,29 | 3,33 | -4,58% | 8,76% | 748.500 |
| 01/12/2017 | 3,55 | 3,56 | 3,33 | 3,49 | -2,24% | 6,48% | 1.016.100 |
| 30/11/2017 | 3,54 | 3,65 | 3,44 | 3,57 | +0,85% | 5,93% | 1.181.000 |
| 29/11/2017 | 3,95 | 4,02 | 3,52 | 3,54 | -9,00% | 12,66% | 5.152.000 |
| 28/11/2017 | 3,95 | 4,10 | 3,79 | 3,89 | +1,30% | 7,85% | 1.416.200 |
| 27/11/2017 | 3,90 | 3,99 | 3,72 | 3,84 | +3,78% | 6,92% | 1.705.000 |
| 24/11/2017 | 3,62 | 3,71 | 3,62 | 3,70 | +1,65% | 2,49% | 241.400 |
| 22/11/2017 | 3,64 | 3,72 | 3,62 | 3,64 | +0,28% | 2,75% | 429.300 |
| 21/11/2017 | 3,68 | 3,73 | 3,61 | 3,63 | -1,63% | 3,26% | 371.200 |